Strainprint President & CTO, David Berg Featured in Cannabis Investing News

Written by Strainprint

The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before.

With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product it doesn’t know everything about.

Read on to hear what Strainprint, President & CTO, David Berg had to say…..

Cannabis & Opioids: An Interview with Dr. Peter Grinspoon

Coinciding with the adult use legalization of cannabis across North America, an opioid epidemic has emerged. It is estimated that more than 130 people die each day due to opioid overdose in the United States alone, according to the U.S. Department of Health and Human Services (HHS). The organization reported that, in 2017, nearly 50,000 Americans […]

Understanding Terpenes: Camphene

Camphene, sometimes called comphene, is one of more than 200 terpenes discovered to date in hemp and cannabis. Terpenes are aromatic molecules once thought to convey only aroma and, from an evolutionary functional perspective, to protect a plant from pests and predators. In recent years, however, much clinical research, in addition to anecdotal evidence, has […]

Top 10 Cannabis Interview Questions You Should Be Ready For

If you’re looking for a job in the cannabis industry, you’ll need to prepare for your upcoming interview. Proper preparation will help you land your cannabis industry dream-job! Not sure where to start? Get some practice with our list of key cannabis interview questions: 1. COMMON INTERVIEW QUESTIONS Like with any industry, your interviewer will want to […]